Michael S. Abrams

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Raynham, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Abrams
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael S. Abrams

Form 4 holding Chief Financial Officer

NRX Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
50,000
Estimated value
$10,000
Report date
07 Feb 2025
Price
$0.2000
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Arch Therapeutics, Inc.

Security class
Warrants (right to buy)
Shares / value
20,584
Estimated value
Report date
31 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Arch Therapeutics, Inc.

Security class
Common Stock
Shares / value
10,292
Estimated value
Report date
31 Aug 2023
Price
Ownership
Direct

Insider Reports Filed by Michael S. Abrams

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .